Pfizer
The Taliban continue crackdown on protests
Top of The World: Demonstrators took to the streets of Kabul Wednesday in defiance of the Taliban. And, A new study by Oxford University in the UK has found that two of the most widely used COVID-19 vaccines weaken within three months. Also, a powerful blast in Pakistan has killed at least three people and wounded around 50 others.
Discussion: The year ahead in the coronavirus pandemic
What will the next year bring in the coronavirus pandemic? As part of The World’s regular series of conversations about COVID-19, reporter Elana Gordon moderated a discussion with epidemiologist Michael Mina from Harvard’s T.H. Chan School of Public Health.
Discussion: Surging coronavirus cases and new vaccines
With spiking coronavirus cases, the US and countries around the globe are looking to measures such as COVID-19 vaccines and rapid self-testing. But steps such as mask-wearing and social distancing remain critical. As part of our regular series of conversations about the pandemic, The World’s Elana Gordon moderated a discussion with Harvard epidemiologist Megan Murray for the latest insights.
Early Moderna data shows coronavirus vaccine 94.5% effective; Violence in Ethiopia threatening international conflict; 15 Asia-Pacific economies sign RCEP
Moderna’s early data shows its coronavirus vaccine is 94.5% effective; And, the violence in Ethiopia’s north is threatening to become an international conflict; Also 15 Asia-Pacific economies, making up 30% of the world’s population and gross domestic product, signed the Regional Comprehensive Economic Partnership trade deal on Sunday.
Patent expires on blockbuster Lipitor drug; generics on the way
After 20 years being the only game in town, Pfizer, the manufacturer of Lipitor, is about to get some competition in the space for treating those with chronic high cholesterol. The patent expired Wednesday and one generic drug is ready to hit the market. Others should arrive in six months.